MYLIP and atherosclerosis: Our data demonstrate that Idol can regulate TG metabolism through the CD36 signaling pathway in hamsters and inactivation of Idol attenuates hyperlipidemia and protects against spontaneous atherosclerosis in setting of FH, suggesting that Idol will be a potential target for the treatment of lipid disorder and ASCVD.